|
 The COVID-19 outbreak, which has upended the U.S. economy and so far
killed about 649,299 people in the country, has drawn renewed
attention to healthcare costs.
In August, President Biden said U.S. prescription drug costs were
two to three times higher than other nations in the world, while
urging lawmakers to enact legislation to lower drug prices.
The U.S. Medicare program is a health insurance program for people
aged 65 and above, and those with disabilities.
The plan, to be released later on Thursday, will back legislation
aimed at lowering drug prices put forth by congressional Democrats,
the WSJ report said.
[to top of second column] |
 It will also outline other
administrative measures such as testing
reimbursement for drugs in Medicare based on the
clinical value they provide to patients and
federal funding for research into new
treatments, the report said.
(Reporting by Mrinalika Roy in Bengaluru;
Editing by Shinjini Ganguli)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
